Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 2/2011

01-06-2011 | Original Article

The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level—a pilot study

Authors: Mamdouh Abdulrhman, Mohamed El-Hefnawy, Rasha Hussein, Ahmad Abou El-Goud

Published in: Acta Diabetologica | Issue 2/2011

Login to get access

Abstract

Our study was a case–control cross-sectional study that was conducted on 20 children and adolescents suffering from type 1 diabetes mellitus and ten healthy non-diabetic children and adolescents serving as controls. The mean age of patients was 10.95 years. Oral sugar tolerance tests using glucose, sucrose and honey and measurement of fasting and postprandial serum C-peptide levels were done for all subjects in three separate sittings. The glycemic index (GI) and the peak incremental index (PII) were then calculated for each subject. Honey, compared to sucrose, had lower GI and PII in both patients (P < 0.001) and control (P < 0.05) groups. In the patients group, the increase in the level of C-peptide after using honey was not significant when compared with using either glucose or sucrose. However, in the control group, honey produced a significant higher C-peptide level, when compared with either glucose or sucrose. In conclusion, honey, because of its lower GI and PII when compared with sucrose, may be used as a sugar substitute in patients with type 1 diabetes mellitus.
Footnotes
1
Beckman, 200 S. Kraemer Blvd, Brea, CA 92621, USA.
 
2
Biosource Europe S.A—Rue de l’industrie 8, 1400 Nivelles, Belgium.
 
Literature
1.
Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM et al (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34(3):362–366PubMed
2.
Jennie BM, Hayne S, Petocz P, Stephen C (2003) Low-glycemic index diets in the management of diabetes. Diabetes Care 26:2261–2267CrossRef
3.
American Diabetes Association (2002) Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25:202–212CrossRef
4.
White JW Jr et al (1962) Composition of American honeys. Tech. Bull. 1261. Agricultural Research Service, USDA, Washington DC
5.
White JW Jr (1980) Detection of honey adulteration by carbohydrate analysis. JAOAC 63(1):11–18
6.
Al Waili NS, Boni NS (2003) Natural honey lowers plasma prostaglandin concentrations in normal individuals. J Med Food 6(2):129–133PubMedCrossRef
7.
Frankel S, Robinson GE, Berenbaum MR (1998) Antioxidant capacity and correlated characteristics of 14 unifloral honeys. J Apic Res 37(1):27–31
8.
Gheldof N, Engeseth NJ (2002) Antioxidant capacity of honeys from various floral sources based on the determination of oxygen radical absorbance capacity and inhibition of in vitro lipoprotein oxidation in human serum samples. J Agric Food Chem 50(10):3050–3055PubMedCrossRef
9.
Gross HB, Polagruto JA, Zhu QY, Kim SH, Schramm DD, Keen CL (2004) Effect of honey consumption on plasma antioxidant status in human subjects. Abstracts of Papers of the American Chemical Society, 227: U29
10.
Molan PC (1992) The antibacterial activity of honey. 1. The nature of the antibacterial activity. Bee World 73(1):5–28 (2. Variation in the potency of the antibacterial activity. Bee World 73(2): 59–76)
11.
Steinberg D, Kaine G, Gedalia I (1996) Antibacterial effect of propolis and honey on oral bacteria. Am J Dent 9(6):236–239PubMed
12.
Molan PC (1997) Honey as an antimicrobial agent. In: Mizrahi A, Lensky Y (eds) Bee products: properties, applications and apitherapy. Plenum, London, pp 27–37
13.
Theunissen F, Grobler S, Gedalia I (2001) The antifungal action of three South African honeys on Candida albicans. Apidologie 32(4):371–379CrossRef
14.
Ionescu-Tirgoviste C, Popa E, Sintu E, Mihalache N, Cheta D, Mincu I (1983) Blood glucose and plasma insulin responses to various carbohydrates in type 2 non-insulin-dependent diabetes. Diabetologia 24:80–84PubMedCrossRef
15.
Shambaugh P, Worthington V, Herbert JH (1990) Differential effects of honey, sucrose, and fructose on blood sugar levels. J Manip Physiol Ther 13:322–325
16.
Samanta A, Burden AC, Jones GR (1985) Plasma glucose responses to glucose, sucrose, and honey in patients with diabetes mellitus: an analysis of glycemic and peak incremental indices. Diabet Med 2:371–373PubMedCrossRef
17.
Al Waili NS (2004) Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose. J Med Food 7(1):100–107PubMedCrossRef
18.
Agrawal OP, Pachauri A, Yadav H, Urmila J, Goswamy HM, Chapperwal A, Bisen PS, Prasad GB (2007) Subjects with impaired glucose tolerance exhibit a high degree of tolerance to honey. J Med Food 10(3):473–478PubMedCrossRef
19.
Ido Y, Vindigni A, Chang K (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277(5325):563–566PubMedCrossRef
20.
Bornet F, Haardt MJ, Costagliola D, Blayo A, Slama G (1985) Sucrose or honey at breakfast have no additional acute hyperglycemic effect over an isoglucidic amount of bread in type 2 diabetic patients. Diabetologia 28(4):213–217PubMedCrossRef
21.
Elliott S, Keim N, Stern J (2002) Fructose, weight gain and the insulin. Am J Clin Nutr 76:911–922PubMed
22.
Watford M (2002) Small amounts of dietary fructose dramatically increase hepatic glucose uptake. Nutr Rev 60(8):253–257PubMedCrossRef
23.
Al-Waili N (2003) Intrapulmonary administrations of natural honey solution, hyperosmolar dextrose or hyperosmolar distill water to normal individuals and to patients with type 2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peak expiratory flow rate. Eur J Med Res 8(7):295–303PubMed
24.
25.
26.
Jenkins DJ (1987) The glycemic index and the dietary treatment of hypertriglyceridemia and diabetes. J Am Coll Nutr 61:11–17
27.
Daniel WW (1995) Biostatistics: a foundation for analysis in the health sciences, 6th edn. Wiley, New York
28.
Ostman E, Liljeberg H, Elmstahl H, Bjorck I (2001) Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr 74(1):96–100PubMed
29.
FAO/WHO (1998) Carbohydrates in human nutrition (Paper No. 66). Food and Agricultural Organization and Geneva, World Health Organization, Rome
30.
Kaye FP, Holt S, Janette C (2002) International table of glycemic index and glycemic load values. Am J Clin Nutr 76:5n56
31.
Wolever TM, Jenkins DJ, Jenkins AL, Josse RG (1991) The glycemic index: methodology and clinical implications. Am J Clin Nutr 54(5):846–854PubMed
32.
Oizumi T, Daimon M, Jimbu Y, Kameda W, Arawaka N, Yamaguchi H, Ohnuma H, Sasaki H, Kato T (2007) A palatinose-based formula improves glucose tolerance, serum free fatty acid levels and body fat composition. Tohoku J Exp Med 212:91–99PubMedCrossRef
33.
Arai H, Mizuno A, Matsuo K, Fukaya M, Sasaki H, Arima H, Matsuura M, Taketani Y, Doi T, Takeda E (2004) Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism 53:977–983PubMedCrossRef
34.
Dahlquist A, Auricchio S, Semenza G, Prader A (1963) Human intestinal disaccharidases and hereditary disaccharide intolerance: the hydrolysis of sucrose, isomaltose, palatinose (isomaltulose), and 1, 6-a-oligosaccharide (isomalto-oligosaccharide) preparation. J Clin Invest 42:556–562CrossRef
35.
Lina BA, Jonker D, Kozianowski G (2002) Isomaltulose (palatinose): a review of biological and toxicological studies. Food Chem Toxicol 40:1375–1381PubMedCrossRef
36.
Liljeberg H, Akerberg A, Bjorck I (1999) Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am J Clin Nutr 69:647–655PubMed
37.
Glinsmann WH, Bowman BA (1993) The public health significance of crystalline fructose, glucose tolerance. Am J Clin Nutr 77(3):612–621
38.
Pozzan R, Dimetz T, Gazolla HM, Gomes MB (1997) Discriminative capacity of fasting C-peptide levels in a functional test according to different criteria of responser to a stimulus; a study of Brazilian insulin-dependent diabetic patients. Braz J Med Biol Res 30(10):1169–1174PubMedCrossRef
39.
Clarson C, Daneman D, Drash AL, Beckert DJ, Ehelich RM (1987) Residual B-cell function in children with IDDM; reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care 10(1):33–38PubMedCrossRef
40.
Eff C, Fabet O, Deckert T (1989) Persistent insulin secretion assessed by plasma C-peptide estimation in long-term juvenile diabetes with a low insulin requirement. Diabetologia 32:305–311CrossRef
41.
Faber OK, Binder C (1977) B-cell function and blood glucose control in insulin dependent diabetes within the first month of insulin treatment. Diabetologia 13:263–268PubMedCrossRef
Metadata
Title
The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level—a pilot study
Authors
Mamdouh Abdulrhman
Mohamed El-Hefnawy
Rasha Hussein
Ahmad Abou El-Goud
Publication date
01-06-2011
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2011
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0167-7

Other articles of this Issue 2/2011

Acta Diabetologica 2/2011 Go to the issue

Original Article

Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity

Original Article

Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland

Original Article

Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study

Original Article

Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes

Original Article

Changes in body weight are significantly associated with changes in fasting plasma glucose and HDL cholesterol in Japanese men without abdominal obesity (waist circumference < 85 cm)

Original Article

The role of endoplasmic reticulum stress in the early stage of diabetic retinopathy

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits